TBPH
Price
$17.95
Change
+$0.17 (+0.96%)
Updated
Nov 13 closing price
Capitalization
908.56M
108 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.98
Change
-$0.27 (-6.35%)
Updated
Nov 13 closing price
Capitalization
221.29M
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TBPH vs VYGR

Header iconTBPH vs VYGR Comparison
Open Charts TBPH vs VYGRBanner chart's image
Theravance Biopharma
Price$17.95
Change+$0.17 (+0.96%)
Volume$817.92K
Capitalization908.56M
Voyager Therapeutics
Price$3.98
Change-$0.27 (-6.35%)
Volume$457.1K
Capitalization221.29M
TBPH vs VYGR Comparison Chart in %
TBPH
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TBPH vs. VYGR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBPH is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (TBPH: $17.95 vs. VYGR: $3.98)
Brand notoriety: TBPH and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TBPH: 214% vs. VYGR: 67%
Market capitalization -- TBPH: $908.56M vs. VYGR: $221.29M
TBPH [@Biotechnology] is valued at $908.56M. VYGR’s [@Biotechnology] market capitalization is $221.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TBPH’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • TBPH’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than TBPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TBPH’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • TBPH’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than VYGR.

Price Growth

TBPH (@Biotechnology) experienced а +20.71% price change this week, while VYGR (@Biotechnology) price change was -5.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

TBPH is expected to report earnings on Mar 02, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($909M) has a higher market cap than VYGR($221M). TBPH has higher P/E ratio than VYGR: TBPH (31.46) vs VYGR (6.00). TBPH YTD gains are higher at: 88.948 vs. VYGR (-25.044). TBPH has higher annual earnings (EBITDA): 46.1M vs. VYGR (-119.18M). TBPH has more cash in the bank: 339M vs. VYGR (43.9M). VYGR has less debt than TBPH: VYGR (40.2M) vs TBPH (46.5M). TBPH has higher revenues than VYGR: TBPH (77.2M) vs VYGR (42.6M).
TBPHVYGRTBPH / VYGR
Capitalization909M221M411%
EBITDA46.1M-119.18M-39%
Gain YTD88.948-25.044-355%
P/E Ratio31.466.00524%
Revenue77.2M42.6M181%
Total Cash339M43.9M772%
Total Debt46.5M40.2M116%
FUNDAMENTALS RATINGS
TBPH vs VYGR: Fundamental Ratings
TBPH
VYGR
OUTLOOK RATING
1..100
2573
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8096
PRICE GROWTH RATING
1..100
3659
P/E GROWTH RATING
1..100
888
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (45) in the Biotechnology industry is in the same range as TBPH (76) in the Pharmaceuticals Other industry. This means that VYGR’s stock grew similarly to TBPH’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TBPH (100) in the Pharmaceuticals Other industry. This means that VYGR’s stock grew similarly to TBPH’s over the last 12 months.

TBPH's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as VYGR (96) in the Biotechnology industry. This means that TBPH’s stock grew similarly to VYGR’s over the last 12 months.

TBPH's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as VYGR (59) in the Biotechnology industry. This means that TBPH’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for TBPH (88) in the Pharmaceuticals Other industry. This means that VYGR’s stock grew significantly faster than TBPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TBPHVYGR
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 5 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
70%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
TBPH
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INPOY6.030.03
+0.50%
InPost S A
BYLB105.00N/A
N/A
Boyle Bancorp, Inc.
BSQKZ67.32N/A
N/A
Block, Inc.
PTNT8.53N/A
N/A
Palatin Technologies, Inc.
JVTSF3.16N/A
N/A
JUVENTUS FOOTBALL CLUB SPA, TORINO

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-3.89%
KYMR - TBPH
48%
Loosely correlated
+0.25%
VYGR - TBPH
40%
Loosely correlated
-0.23%
VERA - TBPH
37%
Loosely correlated
+4.61%
AXON - TBPH
34%
Loosely correlated
-0.47%
ARRY - TBPH
34%
Loosely correlated
-8.69%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.23%
RGNX - VYGR
54%
Loosely correlated
+0.43%
IMTX - VYGR
53%
Loosely correlated
+16.10%
KYMR - VYGR
52%
Loosely correlated
+0.25%
IMNM - VYGR
52%
Loosely correlated
-0.51%
XNCR - VYGR
51%
Loosely correlated
-3.23%
More